Genzyme Unit Sale May Push Sanofi to Raise Offer

Genzyme Corp., a takeover target of Sanofi-Aventis SA, agreed to sell its diagnostic testing unit to Laboratory Corp. of America Holdings for $925 million in cash.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.